AmotL2, IQGAP1, and FKBP51 Scaffold Proteins in Glioblastoma Stem Cell Niches

J Histochem Cytochem. 2022 Jan;70(1):9-16. doi: 10.1369/00221554211025480. Epub 2021 Jun 24.

Abstract

Glioma stem cells (GSCs) live in a continuous process of stemness reprogramming to achieve specific cell commitment within the so-called GSC niches, specifically located in periarteriolar regions. In this review, we analyze the expression levels, cellular and subcellular location, and role of three scaffold proteins (IQGAP1, FKBP51, and AmotL2) in GSC niches. Scaffold proteins contribute to cell differentiation, migration, and angiogenesis in glioblastoma. It could be of diagnostic interest for establishing stages, for therapeutic targets, and for improving glioblastoma prognosis, which is still at the experimental level.

Keywords: AmotL2; IQGAP1; and FKBP51; angiogenesis; glioblastoma stem cells; scaffold proteins; stem cell niche; stemness; tumor heterogeneity; tumor immune infiltrate; tumor microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiomotins / genetics*
  • Cell Differentiation
  • Glioblastoma / diagnosis
  • Glioblastoma / drug therapy
  • Glioblastoma / genetics*
  • Humans
  • Neoplastic Stem Cells
  • Tacrolimus Binding Proteins / genetics*
  • ras GTPase-Activating Proteins / genetics*

Substances

  • AMOTL2 protein, human
  • Angiomotins
  • IQ motif containing GTPase activating protein 1
  • ras GTPase-Activating Proteins
  • Tacrolimus Binding Proteins
  • tacrolimus binding protein 5